Antithrombin III (AT-III) is a blood protein that inhibits or stops the clotting factors in blood. Approximately 75% of the body's plasma coagulation inhibitory activity is derived from AT-III. AT-III deficiency is a rare inherited or spontaneously occurring condition that affects one in every 2,000 to 5,000 males and females worldwide. Individuals with the condition lack the AT-III protein and spontaneous clotting can occur as a result of normal, daily activity. A doctor or healthcare provider prescribes Antithrombin III.
Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition, approved indications (uses), product labels, and packaging for a prescription drug may differ between countries. Please refer to the prescribing information provided for your country of residence.
Thrombate III®, Antithrombin III (Human) reaches patients around the world.
|
